Health & Personal Care
HIGH
FDA DRUG
Major Pharmaceuticals Gabapentin 100 mg 10-Capsule Recall Nationwide 2025
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, 10 capsules per blister pack, distributed nationwide in the United States. The recall cites failed impurities and degradation specifications from routine stability testing, specifically an out-of-spec Highest Unknown Impurity. Consumers and healthcare providers should stop using this product immediately and contact The Harvard Drug集团
Gabapentin
Failed Impurities/Degradation